Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRIM24 | O15164 | 1/20 | 0.31 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.31 |
| ▸ | CCR1 | P32246 | 1/20 | 0.31 |
| ▸ | ERN1 | O75460 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1584446 | 0.79 | ALDH1A1 (0.35) | CCR1 | |
| SCHEMBL15990229 | 0.79 | ERN1 (0.41) | TRIM24TRIM33ERN1 | |
| SCHEMBL30139595 | 0.79 | ERN1 (0.32) | ERN1 | |
| SCHEMBL1574793 | 0.79 | — | — | |
| SCHEMBL840004 | 0.79 | ERN1 (0.32) | ERN1 | |
| SCHEMBL24609032 | 0.79 | RRM2 (0.45) | — | |
| SCHEMBL29706502 | 0.79 | ALDH1A1 (0.35) | CCR1 | |
| SCHEMBL31337139 | 0.79 | ALDH1A1 (0.32) | — | |
| SCHEMBL22342564 | 0.79 | ALDH1A1 (0.32) | — | |
| SCHEMBL15927725 | 0.76 | CCR1 (0.37) | CCR1ERN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 182 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12636279-B2 | Choline salt forms of an HIV capsid inhibitor | GILEAD SCIENCES, INC. (US) | 2026-05-26 | — | — | US | disclosed |
| CN-116854630-B | Methods and intermediates for preparing therapeutic compounds useful in the treatment of retroviral infections | 吉利德科学公司 | 2026-05-19 | — | — | CN | disclosed |
| US-12594267-B2 | Capsid inhibitors for the treatment of HIV | GILEAD SCIENCES, INC. (US) | 2026-04-07 | — | — | US | disclosed |
| US-12492189-B2 | Solid forms of an HIV capsid inhibitor | GILEAD SCIENCES, INC. (US) | 2025-12-09 | — | — | US | disclosed |
| CN-120078775-A | Capsid inhibitors for the treatment of HIV | 吉利德科学公司 | 2025-06-03 | — | — | CN | disclosed |
| CN-120053445-A | Capsid inhibitors for the treatment of HIV | 吉利德科学公司 | 2025-05-30 | — | — | CN | disclosed |
| CN-120053446-A | Capsid inhibitors for the treatment of HIV | 吉利德科学公司 | 2025-05-30 | — | — | CN | disclosed |
| CN-120053447-A | Capsid inhibitors for the treatment of HIV | 吉利德科学公司 | 2025-05-30 | — | — | CN | disclosed |
| CN-119954778-A | Synthesis method of lenacipam sodium and series of intermediate compounds thereof | 杭州科巢生物科技有限公司 | 2025-05-09 | — | — | CN | disclosed |
| US-20250100999-A1 | METHODS AND INTERMEDIATES FOR PREPARING THERAPEUTIC COMPOUNDS | GILEAD SCIENCES, INC. | 2025-03-27 | — | — | US | disclosed |
| WO-2014110297-A1 | (HETERO) ARYLACETAMIDE DERIVATIVES AS ANTIRETROVIRAL AGENTS | GILEAD SCIENCES, INC. (US) | 2014-07-17 | — | — | WO | disclosed |
| WO-2014110297-A1 | (HETERO) ARYLACETAMIDE DERIVATIVES AS ANTIRETROVIRAL AGENTS | GILEAD SCIENCES, INC. (US) | 2014-07-17 | — | — | WO | disclosed |
| US-8283358-B2 | N-sulfonamido polycyclic pyrazolyl compounds | ELAN PHARMACEUTICALS, INC. (US) | 2012-10-09 | — | — | US | disclosed |
| US-8283358-B2 | N-sulfonamido polycyclic pyrazolyl compounds | ELAN PHARMACEUTICALS, INC. (US) | 2012-10-09 | — | — | US | disclosed |
| US-8283358-B2 | N-sulfonamido polycyclic pyrazolyl compounds | ELAN PHARMACEUTICALS, INC. (US) | 2012-10-09 | — | — | US | disclosed |
| EP-2346863-A2 | N-SULFONAMIDO POLYCYCLIC PYRAZOLYL COMPOUNDS | Elan Pharmaceuticals Inc. (US) | 2011-07-27 | — | — | EP | disclosed |
| US-20100081680-A1 | N-SULFONAMIDO POLYCYCLIC PYRAZOLYL COMPOUNDS | ELAN PHARMACEUTICALS, INC. | 2010-04-01 | — | — | US | disclosed |
| US-20100081680-A1 | N-SULFONAMIDO POLYCYCLIC PYRAZOLYL COMPOUNDS | ELAN PHARMACEUTICALS, INC. | 2010-04-01 | — | — | US | disclosed |
| US-20100081680-A1 | N-SULFONAMIDO POLYCYCLIC PYRAZOLYL COMPOUNDS | ELAN PHARMACEUTICALS, INC. | 2010-04-01 | — | — | US | disclosed |
| WO-2010028213-A2 | N-SULFONAMIDO POLYCYCLIC PYRAZOLYL COMPOUNDS | ELAN PHARMACEUTICALS, INC. (US) | 2010-03-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12636279-B2 | Choline salt forms of an HIV capsid inhibitor | CHKA, SLC5A7, SLC44A1 | TRIM24 1237/4885TRIM33 1918/4885CCR1 165/4885 |
| US-12594267-B2 | Capsid inhibitors for the treatment of HIV | CTDSP1, POLR2H, POLR2E | TRIM24 560/4885TRIM33 270/4885CCR1 1122/4885 |
| US-20250100999-A1 | METHODS AND INTERMEDIATES FOR PREPARING THERAPEUTIC COMPOUNDS | CYP11A1, CYP11B1, CYP11B2 | TRIM24 4841/4885TRIM33 4856/4885CCR1 448/4885 |
| US-20100081680-A1 | N-SULFONAMIDO POLYCYCLIC PYRAZOLYL COMPOUNDS | PSEN1, PSEN2, SULT1E1 | TRIM24 4386/4885TRIM33 4446/4885CCR1 1736/4885 |
| US-12492189-B2 | Solid forms of an HIV capsid inhibitor | ZC3HAV1, GTF3C3, ZC3HAV1L | TRIM24 697/4885TRIM33 1693/4885CCR1 200/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.